6 results for author:"Miralpeix M." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Pyrazine-based Syk kinase inhibitors. Forns P., Esteve C., Taboada L., Alonso J.A., Orellana A., Maldonado M., Carreno C., Ramis I., Lopez M., Miralpeix M. et al. Bioorg. Med. Chem. Lett. 22:2784-2788(2012) · Mapped (1) |
| Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice. Carpenter K.J., Ewing J.L., Schuh J.M., Ness T.L., Kunkel S.L., Aparici M., Miralpeix M., Hogaboam C.M. Br. J. Pharmacol. 145:1160-1172(2005) · Mapped (1) |
| Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Romero X., Benitez D., March S., Vilella R., Miralpeix M., Engel P. Tissue Antigens 64:132-144(2004) · UniProtKB (1) |
| The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Pons S., Asano T., Glasheen E., Miralpeix M., Zhang Y., Fisher T.L., Myers M.G. Jr., Sun X.J., White M.F. Mol. Cell. Biol. 15:4453-4465(1995) · UniProtKB (1) · Mapped (13) |
| Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Sun X.-J., Crimmins D.L., Myers M.G. Jr., Miralpeix M., White M.F. Mol. Cell. Biol. 13:7418-7428(1993) · UniProtKB (1) |
| Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. Backer J.M., Myers M.G. Jr., Shoelson S.E., Chin D.J., Sun X.-J., Miralpeix M., Hu P., Margolis B., Skolnik E.Y., Schlessinger J. et al. EMBO J. 11:3469-3479(1992) · UniProtKB (1) |